Greater occipital nerve block for a sooner en and better treatment of cluster headache

Phase 1

• Conditions: Episodic cluster headache; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2018-002224-17-NL
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-20
• Last Update Posted: 30 June 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

- Patients have to be diagnosed with episodic cluster headache according to the international classification of headache disorders – third edition beta, ICHD-3b
- Patients have to be aged 18-65 years
- Patients need to be newly diagnosed and treatment naïve, or already diagnosed and currently free from prophylactic treatment
- Patients need to have a mean of more than 1 attack per day in the 3 days preceding inclusion.
- Patients should be in their cluster period for shorter than 4 weeks before inclusion.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- A contraindication for treatment with steroids or verapamil
- The use of anticoagulants or known bleeding disorder.
- Use of any prophylactic medication for cluster headache
- Patients with a history of other primary headache who are currently using prophylactic medication for this headache
- Pregnancy

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified